Braidwell’s Evolus EOLS Stock Holding History

Braidwell’s Portfolio EOLS Stock Details EOLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21.9M	Buy	3,155,209 +50,000	+2%	+$295K	0.81%	49
2026 Q1	$12.8M	Hold	3,105,209	–	–	0.43%	68
2025 Q4	$20.6M	Buy	+3,105,209	New	+$21M	0.66%	51

Other funds holding EOLS

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Braidwell's EOLS Position: Q2 2026 in Review

Braidwell increased its Evolus (EOLS) stake by 1.6% in Q2 2026, buying an estimated $295K and bringing the position to 3,155,209 shares worth $21.9M. The position accounts for 0.81% of the portfolio, ranked #49.

Braidwell first reported a position in EOLS in Q4 2025 and has held it in 3 quarters since. 158 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.

Braidwell held 3,155,209 shares of Evolus worth $21.9M as of Q2 2026.
Braidwell bought 50,000 Evolus shares in Q2 2026, an estimated $295K.
Evolus made up 0.81% of Braidwell's portfolio in Q2 2026, its #49 holding.
Braidwell first reported a position in Evolus in Q4 2025 and has held it in 3 quarters since.
158 funds tracked by Wall St. Rank held Evolus as of Q2 2026.

Based on Braidwell's 13F filing for Q2 2026, filed 14 Aug 2026.